Week in Washington
The biopharma industry is asking for a three-month grace period on implementation of the Physicians Payment Sunshine provision, since the Department of Health and Human Services has not yet developed guidance.
Par Pharmaceutical Inc. filed suit against the FDA for violating the Federal Food, Drug and Cosmetic Act and the First Amendment by restricting truthful speech about approved uses of drugs.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST